NO20041058L - Preparater og fremgangsmater relatert til nye benzodiazepinforbindelser og mal derav - Google Patents
Preparater og fremgangsmater relatert til nye benzodiazepinforbindelser og mal deravInfo
- Publication number
- NO20041058L NO20041058L NO20041058A NO20041058A NO20041058L NO 20041058 L NO20041058 L NO 20041058L NO 20041058 A NO20041058 A NO 20041058A NO 20041058 A NO20041058 A NO 20041058A NO 20041058 L NO20041058 L NO 20041058L
- Authority
- NO
- Norway
- Prior art keywords
- preparations
- forms
- methods related
- benzodiazepine compounds
- new benzodiazepine
- Prior art date
Links
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31256001P | 2001-08-15 | 2001-08-15 | |
| US31368901P | 2001-08-20 | 2001-08-20 | |
| US39667002P | 2002-07-18 | 2002-07-18 | |
| US10/217,878 US20030119029A1 (en) | 1999-04-30 | 2002-08-13 | Compositions and methods relating to novel benzodiazepine compounds and targets thereof |
| PCT/US2002/026171 WO2003015703A2 (fr) | 2001-08-15 | 2002-08-15 | Compositions et procedes relatifs a de nouveaux composes de benzodiazepine et leurs cibles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20041058L true NO20041058L (no) | 2004-05-14 |
Family
ID=27499087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20041058A NO20041058L (no) | 2001-08-15 | 2004-03-12 | Preparater og fremgangsmater relatert til nye benzodiazepinforbindelser og mal derav |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1423122A4 (fr) |
| JP (1) | JP2005502652A (fr) |
| AU (1) | AU2002332560B2 (fr) |
| CA (1) | CA2457405A1 (fr) |
| MX (1) | MXPA04001421A (fr) |
| NO (1) | NO20041058L (fr) |
| NZ (1) | NZ531117A (fr) |
| WO (1) | WO2003015703A2 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050113460A1 (en) * | 1999-04-30 | 2005-05-26 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
| JP5127096B2 (ja) | 1999-04-30 | 2013-01-23 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | アポトーシスにより誘導される自己免疫疾患を処置するためのベンゾジアゼピンの使用 |
| US7276348B2 (en) | 1999-04-30 | 2007-10-02 | Regents Of The University Of Michigan | Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof |
| US7144880B2 (en) | 1999-04-30 | 2006-12-05 | Regents Of The University Of Michigan | Compositions relating to novel compounds and targets thereof |
| US20060025388A1 (en) * | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
| CA2524394C (fr) * | 2003-05-01 | 2011-07-12 | The Regents Of The University Of Michigan | Nouvelles benzodiazepines, compositions de celles-ci et leurs utilisations |
| US20050272723A1 (en) * | 2004-04-27 | 2005-12-08 | The Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| JP2008528448A (ja) | 2005-01-03 | 2008-07-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 新規化合物に関連する組成物および方法、ならびにその標的 |
| JP2008545757A (ja) * | 2005-06-01 | 2008-12-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 溶媒和されていないベンゾジアゼピン組成物および方法 |
| BRPI0520554A2 (pt) | 2005-09-19 | 2009-06-13 | Arrow Therapeutics Ltd | uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica |
| EP1948191B1 (fr) | 2005-11-01 | 2013-01-16 | The Regents of the University of Michigan | Nouvelles 1,4-benzodiazépine-2,5-diones dotées de propriétés thérapeutiques |
| US7759338B2 (en) | 2006-04-27 | 2010-07-20 | The Regents Of The University Of Michigan | Soluble 1,4 benzodiazepine compounds and stable salts thereof |
| EP2418206A3 (fr) | 2006-06-09 | 2012-06-27 | The Regents of the University of Michigan | Dérivés de benzodiazépine pour le traitment des troubles auto-immuns |
| KR101164718B1 (ko) | 2007-03-09 | 2012-07-11 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 신규 화합물 및 이의 표적에 관한 조성물 및 방법 |
| MX2010002732A (es) | 2007-09-14 | 2010-06-02 | Univ Michigan | Inhibidores de f1f0-atpasa y metodos relacionados. |
| CN101918375A (zh) | 2007-11-06 | 2010-12-15 | 密歇根大学董事会 | 在皮肤病症的治疗中有用的苯并二氮杂*酮化合物 |
| US8497307B2 (en) | 2008-09-11 | 2013-07-30 | The Regents Of The University Of Michigan | Aryl guanidine F1F0-ATPase inhibitors and related methods |
| WO2010121164A2 (fr) | 2009-04-17 | 2010-10-21 | The Regents Of The University Of Michigan | Composés de 1,4-benzodiazépinone et leur utilisation dans le traitement du cancer |
| EP2470020A4 (fr) | 2009-09-18 | 2013-03-13 | Univ Michigan | Composés de benzodiazépinone et méthodes de traitement les utilisant |
| JP5856064B2 (ja) | 2009-11-17 | 2016-02-09 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 治療特性を有する１，４−ベンゾジアゼピン−２，５−ジオンおよび関連化合物 |
| WO2011062765A2 (fr) | 2009-11-17 | 2011-05-26 | The Regents Of The University Of Michigan | 1,4-benzodiazépine-2,5-diones et composés apparentés présentant des propriétés thérapeutiques |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898861A (en) * | 1987-03-26 | 1990-02-06 | Hoffmann-La Roche Inc. | Method for inhibiting the proliferation of tumor cells |
| US5776946A (en) * | 1995-08-28 | 1998-07-07 | Mcgeer; Patrick L. | Peripheral benzodiazepine receptor ligands as antiinflammatory agents |
| WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
| FR2779963A1 (fr) * | 1998-06-22 | 1999-12-24 | Centre Nat Rech Scient | Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer |
| US6277844B1 (en) * | 1998-09-14 | 2001-08-21 | Sydney Spector | Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis |
| JP5127096B2 (ja) * | 1999-04-30 | 2013-01-23 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | アポトーシスにより誘導される自己免疫疾患を処置するためのベンゾジアゼピンの使用 |
| EP1210596A2 (fr) * | 1999-06-22 | 2002-06-05 | Mitokor | Compositions et procedes d'analyse de conditions infracellulaires et traitement par transert d'energie |
| US7005274B1 (en) * | 1999-09-15 | 2006-02-28 | Migenix Corp. | Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass |
| US20020039746A1 (en) * | 2000-01-14 | 2002-04-04 | Sjoberg Eric Richard | Methods for identifying peripheral benzodiazepine receptor binding agents |
-
2002
- 2002-08-15 EP EP02794914A patent/EP1423122A4/fr not_active Withdrawn
- 2002-08-15 WO PCT/US2002/026171 patent/WO2003015703A2/fr not_active Ceased
- 2002-08-15 MX MXPA04001421A patent/MXPA04001421A/es not_active Application Discontinuation
- 2002-08-15 AU AU2002332560A patent/AU2002332560B2/en not_active Ceased
- 2002-08-15 NZ NZ531117A patent/NZ531117A/xx not_active IP Right Cessation
- 2002-08-15 JP JP2003520664A patent/JP2005502652A/ja active Pending
- 2002-08-15 CA CA002457405A patent/CA2457405A1/fr not_active Abandoned
-
2004
- 2004-03-12 NO NO20041058A patent/NO20041058L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ531117A (en) | 2006-03-31 |
| EP1423122A2 (fr) | 2004-06-02 |
| WO2003015703A3 (fr) | 2003-11-13 |
| WO2003015703A2 (fr) | 2003-02-27 |
| MXPA04001421A (es) | 2004-06-03 |
| EP1423122A4 (fr) | 2008-12-10 |
| JP2005502652A (ja) | 2005-01-27 |
| CA2457405A1 (fr) | 2003-02-27 |
| AU2002332560B2 (en) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20041058L (no) | Preparater og fremgangsmater relatert til nye benzodiazepinforbindelser og mal derav | |
| DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
| DK1370128T3 (da) | Kombineret ballepresse og ballevikler | |
| NO20032332D0 (no) | Benzodiazepinderivatforbindelser, fremgangsmåte til fremstilling og anvendelse derav | |
| NO20035325D0 (no) | Hudpermeabelt selektiv cyklooksygenase-2-inhibitorpreparat | |
| DK1539224T3 (da) | Antimikrobielt præparat og fremgangsmåde til anvendelse | |
| DK1746375T3 (da) | Oxygendrevet forbrændingssystem og anvendelser deraf | |
| IS7188A (is) | Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun | |
| CY2013011I1 (el) | Μεθοδος χορηγησης διφωσφονικων | |
| NO20044192L (no) | 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater | |
| NO20040072L (no) | Nye substituerte benzimidazol-doseringsformer og fremgangsmate for anvendelse av samme | |
| DK1390389T3 (da) | Cripto-blokerende antistoffer og anvendelser deraf | |
| NO20033387D0 (no) | Modifiserte antistoffer og fremgangsmåter for anvendelse | |
| DK1249151T3 (da) | Fremgangsmåde til cellegenvalgssignalering | |
| DK1511734T3 (da) | Forbindelser, præparater og fremgangsmåder | |
| DK1429769T3 (da) | Nye formuleringer og anvendelse deraf | |
| ID30187A (id) | Dongkrak jenis pantagraf | |
| NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
| IS6401A (is) | Efnafræðilegar aðferðir og milliefni | |
| DK1311731T3 (da) | Fremgangsmåde og arrangement til stolpesystem | |
| NO20033506D0 (no) | Parasittdrepende preparater og fremgangsmåter for anvendelse | |
| NO20035328D0 (no) | Nye forbindelser og preparater som katepsinhibitorer | |
| NO20030843D0 (no) | Anordning og fremgangsmåte for kultivering | |
| IS7798A (is) | Efnasambönd, lyfjablöndur og aðferðir | |
| NO20030822L (no) | Nye forbindelser og fremgangsmåter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |